We know "down-regulation", in which the number of insulin receptors decreases with insulin treatment (Gavin et al., 1974 ; Blackard et al., 1978 ; Livingston et al., 1978 ; Petersen et al., 1978) , and "upregulation", in which the number of insulin receptors increases with gulcocorticoid treatment (Fantus et al., 1981 ; Knutson et al., 1982) , to regulate insulin receptors. Recently, Stevens et al. (1983) showed that insulin increased its binding sites in cultured chondrosarcoma chondrocytes.
In some experiments, however, glucocorticoids decreased insulin binding sites (Cigolini and Smith, 1972 ; Kahn et al., 1979 ; Olefsky et al., 1975) . It was reported that fatty acids decreased insulin binding and insulin action (Grunfeld et al., 1981) . We do not, however, clearly understand how those phenomena are involved in the physiological functions of insulin, even though other groups have pointed out that down-regulation contributes to the biological functions of insulin in cultured cells (Caro and Amatruda, 1982) .
In this paper, we show that dexamethasone increased the number of high affinity insulin binding sites without changing the apparent equilibrium constant in cultured human urinary bladder carcinoma cells (JTC-32) (Kakuya et al., 1983 into cells. In order to know which part was increased by dexamethasone, after the cells were incubated with 125I-labeled insulin, they were exposed to fresh medium containing a large excess of unlabeled insulin ; the released radioactivity would mainly represent insulin bound to the cell surface, and the remaining radioactivity would represent insulin taken into the cells.
The treatment of cells with dexamethasone induced a 1.9-fold increase in insulin binding to the cell surface, and a 1.7-fold increase in insulin internalization (Table 1) . The increase in the total cellular radioactivity with dexamethasone was almost equal to the increase in the released radioactivity. from the cell surface. In other words, dexamethasone increased insulin binding in JTC-32 cells. No significant difference in the nonspecific insulin binding was observed between the control and dexamethasone-treated cells.
It was reported by Ozaki and Kalant (1977) that the incubation of insulin with plasma membranes induced the degradation of insulin. We therefore measured the increase in the radioactivity of the trichloroacetic acid-soluble fraction of the medium used for insulin treatment with cells. When the fresh cells, untreated with dexamethasone, were incubated with 125I-labeled the stated periods, insulin binding increased during the entire 24 h of incubation, as shown in Fig. 2 . After the 24 h of incubation, insulin binding increased to 145 % of the control cells which were not pretreated with dexamethasone. Therefore, for the subsequent experiments, in which the cells were pretreated with dexamethasone, the period of preincubation of the cells with the hormone was 24 h to get a high insulin binding factor.
The effect of dexamethasone on insulin binding was investigated with various concentrations of dexamethasone (Table 2) . A significant effect of dexamethasone was found at 10 nM. In our previous experiments sites were almost the same in the fresh and dexamethasone-treated cells. Regarding low affinity insulin binding sites, the dexamethasone treatment induced a 1.6-fold increase in the number of binding sites, although there was a slight difference between apparent equilibrium constants in the two samples. After JTC-32 cells were treated with insulin, dexamethasone or insulin plus dexamethasone, the number of cells and the amount of cellular proteins per dish were measured (Table 4) . Neither insulin nor dexamethasone affected the number of, or the amount of cellular proteins. However, when the cells were pretreated with dexamethasone and further treated with dexamethasone plus insulin, not only the number of cells but also the amount of cellular proteins increased slightly, even though these increases were very small.
Discussion
In this study, the number of high affinity insulin binding sites increased without changing the apparent equilibrium constant with the pretreatment of the cells with dexamethasone. Similar results were reported by Fantus et al. (1981) and Knutson et al. (1982) . The latter (Knutson et al., 1982) showed that an increase in the number of insulin binding sites with dexamethasone was due to a decrease in the degradation rate of insulin receptors. Furthermore, dexamethasone changed preadipocytes to adipocytes, accompained by an increase in the number of insulin receptors while changing the affinity for insulin (Rubin et al., 1978) . In the latter case, however, it appeared that the changes in insulin receptors were due to cell differentiation with dexamethasone rather than changes in insulin receptors themselves the differentiation of cells eventually caused the changes in insulin receptors on the cells.
Among the various cell lines examined in our study, dexamethasone increased the number of insulin receptors (up-regulation) only in HTC cells, derived from rat hepatoma, and JTC-32 cells. In HTC cells, the cellular morphology was altered by dexamethasone, and the preincubation of the cells with this hormone was necessary for the induction of tyrosine aminotransferase activity with insulin (Sorimachi et al., 1983) .
Although dexamethasone did not alter the cellular morphology in JTC-32 cells (unpublished data), this hormone increased the number of high affinity insulin binding sites. In addition, although neither insulin nor dexamethasone increased the number of cells or the amount of cellular proteins per dish, the addition of insulin to the incubation medium, in which the cells were preincubated with dexamethasone, increased them. Judging from these results, the increase in the number of insulin receptors with dexamethasone might contribute to the appearance of insulin effects. It is known that insulin stimulates the incorporation of thymidine into fibrobrasts, even though this effects is very weak (Perdue and Raizada, 1976) .
In our previous results related to the induction of tyrosine aminotransferase activity with insulin in HTC cells (Sorimachi et al., 1983) 
